/lfs1/sudharao/PubMedCentral-Corpus/articles.O-Z/Thromb_Res_Suppl/Thromb_Res_Suppl_2014_Jan_133(1)_80-87.nxml
('Myb', 'MYB', 'increases')
A similar situation was observed with Myb genes; many members were expressed, but only Myb-like DNA-binding protein (MZ00044429, MZ00018761), and GAMYB-binding protein (MZ00024498) were up-regulated in inoculated S. Of the ethylene responsive factors, ERF3 (MZ00018574, MZ00026596) was up-regulated in inoculated R. ERF (MZ00016032), ethylene-responsive factor-like protein 1(MZ00019568, MZ00030445), and ERF3 (MZ00018574) were up-regulated in inoculated S.

('Raf', 'MEK', 'adds_modification')
Effects of Ras, Raf, MEK1/2 and MAPK inhibition on potentiation of nerve growth factor (NGF)-induced neurite outgrowth by aripiprazole.
< Ras-Raf-MEK-ERK pathway>
FKN stimulates angiogenesis by activating the Raf-1/MEK/ERK and PI3K/Akt/eNOS/NO signal pathways via the G protein-coupled receptor CX3CR1 [
(1) The expression amount of p42.3 in G1 and M phase was higher than that in S and G2 phase; (2) The space coordinate systems of different structural domains of p42.3 protein were established in Matlab7.0 software; (3) The optimal pathway of p42.3 gene in protein regulatory network in gastric cancer is Ras protein, Raf-1 protein, MEK, MAPK kinase, MAPK, tubulin, spindle protein, centromere protein and tumor.
In addition, RTK transduction also activates downstream Raf/MEK/ERK signaling cascades.
The RTK-related pathways, including the Ras-Raf-MEK-ERK cascades and phosphatidylinositol 3-kinase (PI3K)-Akt pathway, are also regulated by miRNAs.
GTP-bound Ras recruits Raf kinases and activates the latter's serine/threonine kinase function to phosphorylate MEK and induce the phosphorylation of ERK effector kinases 
In the case of the ERK1/2 pathway, amplification occurs at the Raf-MEK step, because MEK1 is much more abundant than Raf.
The data concerning Raf and MEK downstream signaling and the discussion whether raf inhibition is reasonable or not is very contradictory and is still in the focus of preclinical investigation.
Several further inhibitors of Raf and MEK are under preclinical assessment in GEP-NENs however with not very promising results to date (refer to 
Another example is the crosstalk between B-Raf/C-Raf and Ras/MEK/ERK-pathway.
Ras activates the downstream Ras/Raf/MEK/ERK pathway, inducing many biological activities involved in tumorigenesis.
Ras regulates multiple signaling pathways of which the best understood is the Ras/Raf/mitogen-activated extracellular protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
These kinases are members of the Raf/MEK/ERK intracellular signaling cascade, a downstream effector of Ras, which in turn can be activated by upstream receptor TK stimulation (
Multiple downstream intracellular signaling pathways such as Ras/Raf/MEK/ERK may as a result be activated, resulting in proliferation, angiogenesis and metastasis.
Sorafenib inhibited activation of the Raf/MEK/ERK pathway in a number of cell lines in Western blot assays and pERK immunoassays (
As mentioned before, the Ras-Raf-MEK-ERK pathway and its interaction with the PI3K-AKT-mTOR pathway is associated with sporadic MTC.
In contrast, in L929 cells OTA and LPS increased the level of pRaf Ser259, which suppresses MEK 1/2 Ser217/221 (
This is similar to observed for cells bearing the V600E mutation in B-Raf, a serine/threonine kinase immediately upstream of MEK1/2 in the of the ERK MAPK cascade.

('MYC', 'NRAS', 'increases')
Complex karyotypic abnormalities in MYC, the activation of NRAS and KRAS, mutations in TP53, and inactivation of CDKN2A and CDKN2C are late-onset translocations and gene mutations that promote a higher rate of progression to MM [

('Ca2+', 'PKC', 'increases_activity')
Those second messengers facilitate actin-myosin interactions by increasing intracellular calcium (Ca2+) concentrations through various mechanisms including activation of receptor-operated Ca2+ channels, voltage-gated Ca2+ channels via protein kinase C (PKC), and emptying of intracellular Ca2+ stores.

('RB1', 'MYC', 'increases')
Although the enhanced expression of the CCND1 gene alone is held responsible for the development of lymphoma, the additional influence of tumor suppressors like TP53 and RB1 and oncogenes like BCL2, CD4, and MYC play a role in the development of MCL [

('PI3K', 'PDK1', 'increases_activity')
CREB, cAMP response element-binding protein; Gab1, GRB2-associated-binding protein 1; MAPK/ERK, mitogen-activated protein kinase/extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase kinase; MTOR, mammalian target of rapamycin; PDK1, pyruvate dehydrogenase lipoamide kinase isozyme 1; PI3K, phosphoinositide 3-kinase; RSK, ribosomal s6 kinase.
Drug resistance is a potential challenge that may arise with the use of mTOR inhibitors, and can be mediated by dysregulation of p27, feedback activation of PI3K/Akt by S6K, activation of the ERK, PIM, and PDK1 pathways, alterations in protein synthesis, and increased bcl-2.
Upstream positive regulators of mTORC1 include PI3K, PDK1, Akt, mTORC2, RHEB, and nutrients leading to increase translation, cell proliferation, and survival.

('DAG', 'PKC', 'increases_activity')
DAG and IP3 promote the activation of a protein kinase C (PKC).

('PI3K', 'AKT1', 'adds_modification')
AKT is mainly activated via the Phosphotidyl Inositol-3 Kinase (PI3K) pathway where PI3K activates PIP2 to PIP3, which in turn will bind to the PH-domain of AKT and alter the conformation of AKT to allow subsequent phosphorylation at a threonine site (Thr308 for AKT1 and Thre 309 for AKT2) and a serine site (Ser473 for AKT1 and Ser474 for AKT2).

('Raf-1', 'MEK', 'adds_modification')
FKN stimulates angiogenesis by activating the Raf-1/MEK/ERK and PI3K/Akt/eNOS/NO signal pathways via the G protein-coupled receptor CX3CR1 [
(1) The expression amount of p42.3 in G1 and M phase was higher than that in S and G2 phase; (2) The space coordinate systems of different structural domains of p42.3 protein were established in Matlab7.0 software; (3) The optimal pathway of p42.3 gene in protein regulatory network in gastric cancer is Ras protein, Raf-1 protein, MEK, MAPK kinase, MAPK, tubulin, spindle protein, centromere protein and tumor.

('MEK', 'ERK', 'adds_modification')
CREB, cAMP response element-binding protein; Gab1, GRB2-associated-binding protein 1; MAPK/ERK, mitogen-activated protein kinase/extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase kinase; MTOR, mammalian target of rapamycin; PDK1, pyruvate dehydrogenase lipoamide kinase isozyme 1; PI3K, phosphoinositide 3-kinase; RSK, ribosomal s6 kinase.
< Ras-Raf-MEK-ERK pathway>
FKN stimulates angiogenesis by activating the Raf-1/MEK/ERK and PI3K/Akt/eNOS/NO signal pathways via the G protein-coupled receptor CX3CR1 [
During retinal regeneration in adult newts, the proto-oncogenes FGF2, FGFR-1/2, MEK1/2, ERK1/2, Hes-1, Notch-1 and Musashi-1, along with retinal transcription factors and stem cell markers such as Pax6 and Chx10, are expressed in RPE-derived cells (Chiba et al. 
In addition, RTK transduction also activates downstream Raf/MEK/ERK signaling cascades.
The RTK-related pathways, including the Ras-Raf-MEK-ERK cascades and phosphatidylinositol 3-kinase (PI3K)-Akt pathway, are also regulated by miRNAs.
GTP-bound Ras recruits Raf kinases and activates the latter's serine/threonine kinase function to phosphorylate MEK and induce the phosphorylation of ERK effector kinases 
Concomitant conformational changes stimulate their serine/threonine kinase activity, dimerization and trigger sequential phosphorylation and activation of their targets MEK and ERK 
In the case of the ERK1/2 pathway, amplification occurs at the Raf-MEK step, because MEK1 is much more abundant than Raf.
Furthermore, studies have demonstrated that also the KSR (kinase suppressor of Ras) scaffold, which maintains the co-localization of RAF, MEK, and ERK during ERK activation, interacts with mTOR, RAPTOR, RICTOR, and the TSC2-activating kinases AMPK and GSK3 
Another example is the crosstalk between B-Raf/C-Raf and Ras/MEK/ERK-pathway.
Ras activates the downstream Ras/Raf/MEK/ERK pathway, inducing many biological activities involved in tumorigenesis.
The downstream pathways activated by ALK include PI3K/Akt, MEK/ERK and the JAK/STAT pathways which lead to cell proliferation and cell survival
The downstream signals of EGFR such as phosphorylation of MEK1/2 and ERK1/2 were also inhibited by wogonin or apigenin.
EGFR, p-EGFR, p-MEK1/2, and p-ERK1/2 antibodies were purchased from Cell Signaling Technology Inc. (Danvers, MA, USA).
Culture medium and 0.5% DMSO did not affect the phosphorylations of EGFR, MEK1/2, and ERK1/2 in NCI-H292 cells.
Ras regulates multiple signaling pathways of which the best understood is the Ras/Raf/mitogen-activated extracellular protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
These kinases are members of the Raf/MEK/ERK intracellular signaling cascade, a downstream effector of Ras, which in turn can be activated by upstream receptor TK stimulation (
Multiple downstream intracellular signaling pathways such as Ras/Raf/MEK/ERK may as a result be activated, resulting in proliferation, angiogenesis and metastasis.
Sorafenib inhibited activation of the Raf/MEK/ERK pathway in a number of cell lines in Western blot assays and pERK immunoassays (
The raf-1/MEK/ERK pathway has long been recognized for its role in cancer biology.
FGFR/MEK/ERK signal-transduction pathways appear to mediate downstream signaling of brachyury in chordomas.
As mentioned before, the Ras-Raf-MEK-ERK pathway and its interaction with the PI3K-AKT-mTOR pathway is associated with sporadic MTC.
Activation of the ERK pathway was shown to be MEK-dependent since cells pre-treated with the MEK inhibitor U0126 did not activate ERK.
This is similar to observed for cells bearing the V600E mutation in B-Raf, a serine/threonine kinase immediately upstream of MEK1/2 in the of the ERK MAPK cascade.
Previous reports indicate that ET impaired cell signaling by reducing the activation of ERK, MEK, and JNK in murine T cells in a cAMP dependent manner [

('MYC', 'MAX', 'increases')
Of special biological interest are the MAX (MYC associated factor X) and PML (promyelocytic leukemia) genes, which were found to be up-regulated in both unselected mononuclear cells and CD34+ selected cells in MDS compared to normal bone marrow and which showed a correlation with progression to advanced disease.
The protein encoded by the MAX gene is a transcription factor that interacts with the MYC oncoprotein to form homodimers and heterodimers.

